Abstract 

The non-ablative 2940-nm Er:YAG laser therapy in SMOOTH mode (Fotona’s HaiRestart® protocol) represents a novel approach to stimulating hair growth. In parallel, plant-derived exosomes have emerged as innovative, ethically sound bioactive carriers with regenerative and anti-inflammatory properties. In combination, both modalities may exert synergistic effects: the laser induces a wound-healing-like stimulus, while exosomes deliver growth factors and regulatory molecules directly to the hair follicles. Preliminary experimental and clinical data suggest that this combination has the potential to enhance the efficacy of alopecia treatments beyond that of monotherapies. 

Background 

Androgenetic alopecia (AGA) and diffuse effluvium are based on multifactorial pathomechanisms, including genetic predisposition, hormonal dysregulation, inflammation of the follicular microenvironment, and impaired microcirculation.1,2 Standard therapies such as minoxidil and finasteride have demonstrated efficacy but require long-term use and are sometimes associated with adverse effects.3 

Against this background, energy-based procedures (e.g., non-ablative Er:YAG laser) and cell-free regenerative approaches (e.g., plant-derived exosomes) are gaining increasing importance. 

Non-Ablative Er:YAG Laser Therapy (HaiRestart®) 

The HaiRestart® protocol employs sub-ablative 2940-nm Er:YAG pulses in SMOOTH mode, which thermally stimulate the epidermis and upper dermis without tissue ablation. This process induces: 

• Activation of regenerative signaling pathways (Wnt/β-catenin, VEGF)4 

• Improvement of microcirculation5 

• Stimulation of dermal papilla cells6 

Clinical studies have reported significant improvements in hair density and quality, particularly in female patients with androgenetic alopecia (AGA). 7 Side effects are limited to transient erythema or mild heat sensations. 

Vegan Exosomes (Exocean®) as Regenerative Bioactive Carriers 

Exosomes are extracellular vesicles (30-150 nm) that transport proteins, miRNAs, and lipids. While conventional exosomes are derived from human or animal cells, plant-derived exosomes provide an ethical, vegan, and immunologically compatible alternative.8,9 

Their mechanisms of action include: 

• Promotion of cell proliferation 

• Reduction of proinflammatory cytokines 

• Activation of growth factors such as VEGF, IGF-1, and FGF10-12 

In hair follicle models, plant-derived exosomes have been shown to prolong the anagen phase and protect follicular cells from oxidative stress.12 

Rationale for the Combination: Laser + Exosomes 

The combination of HaiRestart® laser therapy and plant-derived exosomes follows a synergistic concept: 

1. Laser-induced permeability: Sub-ablative thermal effects facilitate the translocation of exosomal vesicles through the epidermal barrier. 

1. Regeneration trigger + growth factor reservoir: While the laser activates wound-healing mechanisms, exosomes deliver bioactive mediators directly to the follicles. 

1. Additive inflammation modulation: Both modalities reduce microinflammatory processes within the follicular microenvironment.6,11 

1. Microcirculation + signal transduction: Improved blood supply (via laser) combined with cellular activation (via exosomes) creates an optimal environment for follicular growth. 

Clinical Perspectives 

The literature on laser-exosome combinations is still limited; however, several advantages have emerged: 

• Enhanced efficacy compared to monotherapy; similar to studies combining laser with minoxidil.13,14 

• Improved tolerability, as both modalities are minimally invasive and low-risk. 

• Multimodal action: structural stimulation (laser) combined with molecular signaling (exosomes). 

Future studies should investigate: 

• Optimal protocols (number of sessions, treatment intervals, exosome dosage) 

• Long-term effects and durability of results 

• Comparisons with PRP and other regenerative approaches 

 Safety 

Both the laser and plant-derived exosome preparations are considered safe: 

• Laser: nearly painless, transient erythema, no scarring.7 

• Exosomes: when applied topically, demonstrate a favorable safety profile in preclinical and clinical studies.8,9,12 

The combination is therefore considered low-risk, provided it is administered by trained healthcare professionals. 

Case Report: Treatment of Hair Loss with HaiRestart® Laser in Combination with Exocean® Exosomes 

A 47-year-old male patient with androgenetic alopecia (Hamilton-Norwood grade IV) underwent a combined therapy consisting of the HaiRestart® laser (Fotona®) and Exocean® exosomes. The treatment aimed to stimulate hair follicles, improve microcirculation, and promote cellular regeneration through exogenous exosomes. 

A total of three treatment sessions were performed at intervals of approximately four weeks. The laser therapy was applied in a non-ablative Er:YAG mode to achieve targeted follicular heating and activation of regenerative processes without epidermal damage. Immediately afterwards, topical application of Exocean® exosomes (~5 ml per session) was performed, with micro-openings created via fractional Er:YAG mode to optimise delivery into the scalp. 

After the second session, the patient reported a marked reduction in perceived hair loss and an improvement in scalp condition, with less seborrhea and flaking. Upon completion of the third session, a visible increase in hair thickness and strength was observed, particularly in the vertex and frontoparietal regions. The patient reported improved hair quality and high satisfaction with the aesthetic outcome. No adverse events or unwanted reactions occurred at any point. 

In summary, the combination of HaiRestart® laser and Exocean® exosomes in this case demonstrated excellent tolerability and a significant improvement in hair density and structure. This method represents an effective, minimally invasive, and regenerative treatment option to support hair growth in androgenetic or diffuse alopecia. 

Before: Image at baseline before the start of treatment 

After: Image four weeks after the third session 

Summary 

The combination of non-ablative Er:YAG laser therapy and vegan exosome preparations represents a promising new approach for stimulating hair growth. Both modalities act through complementary mechanisms – thermal regeneration and exosomal signaling – and may enhance efficacy in androgenetic alopecia (AGA) and diffuse effluvium. 

However, current observations are primarily based on individual case reports and small observational studies; large-scale, randomised, controlled trials are still lacking and will be necessary to fully assess efficacy and safety. 

Although the current evidence remains limited, this combination therapy expands the available spectrum of treatment options and can be used adjunctively with established therapies such as minoxidil, finasteride, or PRP.